[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SG11202111993SA - Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors - Google Patents

Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors

Info

Publication number
SG11202111993SA
SG11202111993SA SG11202111993SA SG11202111993SA SG11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA SG 11202111993S A SG11202111993S A SG 11202111993SA
Authority
SG
Singapore
Prior art keywords
inhibitors
intermediates
preparing
preparation
xpo1
Prior art date
Application number
SG11202111993SA
Other languages
English (en)
Inventor
Brian Clinton Austad
David G Roe
Original Assignee
Karyopharm Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karyopharm Therapeutics Inc filed Critical Karyopharm Therapeutics Inc
Publication of SG11202111993SA publication Critical patent/SG11202111993SA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202111993SA 2019-05-01 2020-05-01 Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors SG11202111993SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962841649P 2019-05-01 2019-05-01
PCT/US2020/031124 WO2020223678A1 (en) 2019-05-01 2020-05-01 Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors

Publications (1)

Publication Number Publication Date
SG11202111993SA true SG11202111993SA (en) 2021-11-29

Family

ID=70802955

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111993SA SG11202111993SA (en) 2019-05-01 2020-05-01 Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors

Country Status (13)

Country Link
US (1) US20220242832A1 (es)
EP (1) EP3962898A1 (es)
KR (1) KR20220004142A (es)
CN (1) CN114040909A (es)
AU (1) AU2020266170A1 (es)
BR (1) BR112021021706A2 (es)
CA (1) CA3135712A1 (es)
CR (1) CR20210590A (es)
IL (1) IL287673A (es)
MA (1) MA55808A (es)
MX (1) MX2021013211A (es)
SG (1) SG11202111993SA (es)
WO (1) WO2020223678A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112679477B (zh) * 2020-12-17 2021-10-26 佛山奕安赛医药科技有限公司 塞利尼索及其中间体的制备方法
CN116514773B (zh) * 2023-04-24 2024-12-03 重庆汉佩生物科技有限公司 一种Verdinexor(KPT-335)及其盐酸盐的合成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230042129A (ko) 2011-07-29 2023-03-27 카리오팜 쎄라퓨틱스, 인코포레이티드 하이드라지드 함유 핵 수송 조절인자 및 이의 용도
RS58058B1 (sr) * 2012-05-09 2019-02-28 Biogen Ma Inc Modulatori nukleusnog transporta i njihove upotrebe
WO2014205393A1 (en) * 2013-06-21 2014-12-24 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
DK3180331T3 (da) 2014-08-15 2022-09-12 Karyopharm Therapeutics Inc Polymorfer af selinexor
WO2017118940A1 (en) * 2016-01-08 2017-07-13 Dr. Reddy's Laboratories Limited Solid forms of selinexor and process for their preparation
US10993943B2 (en) * 2017-01-05 2021-05-04 Watson Laboratories Inc. Crystalline forms of selinexor and process for their preparation

Also Published As

Publication number Publication date
IL287673A (en) 2021-12-01
AU2020266170A1 (en) 2021-11-25
MA55808A (fr) 2022-03-09
JP2022531576A (ja) 2022-07-07
WO2020223678A1 (en) 2020-11-05
CN114040909A (zh) 2022-02-11
EP3962898A1 (en) 2022-03-09
US20220242832A1 (en) 2022-08-04
MX2021013211A (es) 2022-03-11
KR20220004142A (ko) 2022-01-11
BR112021021706A2 (pt) 2022-04-19
CR20210590A (es) 2022-03-11
CA3135712A1 (en) 2020-11-05

Similar Documents

Publication Publication Date Title
IL281082A (en) Preparations of CXCR4 inhibitors and methods of preparation and use
IL281152A (en) Process for preparing JAK inhibitors and their intermediates
ZA202101214B (en) Process and intermediates for the preparation of bilastine
ZA202003590B (en) Process for the preparation of opicapone and intermediates thereof
IL290185A (en) Crystalline forms of risdiplam and their preparation process
IL264854A (en) Spt5 inhibitors and methods of use thereof
IL287673A (en) Process for preparing xpo1 inhibitors and intermediates for use in preparing xpo1 inhibitors
IL272837A (en) A process for preparing tubolysins and their intermediates
ZA202201324B (en) Abrasive article and method of forming
IL290169A (en) Method and intermediates for the preparation of pyroxulfone
IL289453A (en) A process for the preparation of ridinilazole and crystalline forms thereof
IL283281A (en) Formulation of contrast media and process for its preparation
GB2589398B (en) Compounds and methods of use
EP3864011A4 (en) Process for preparation of eribulin and intermediates thereof
HUE058259T2 (hu) Eljárás lubiproszton és annak intermedierei elkészítésére
PL3737685T3 (pl) Sposób wytwarzania kryzaborolu i jego związków pośrednich
ZA202107053B (en) Novel process for the preparation of filgotinib and intermediates thereof
LT4073051T (lt) Būdas ir tarpinis junginys, skirti oksetan-2-ilmetanamino gavimui
ZA202107810B (en) Crystal form of phosphodiesterase inhibitor, preparation method therefor and use thereof
IL278549B1 (en) Intermediates and processes for the preparation of linagliptin and its salts
PT3969459T (pt) Processo e intermediários para a preparação de eldecalcitol
HUP2100077A1 (hu) Eljárás avapritinib és intermedierek elõállítására
EP4051681A4 (en) PROCESS FOR MANUFACTURE OF TOFACITINIB AND INTERMEDIATE THEREOF
GB201911627D0 (en) Polymorph of venetoclax and method for preparing the polymorph
GB201908573D0 (en) Compounds and methods of use